Skip to main content

Lane Michael's Form 4 filing

IDEXX Laboratories Inc (IDXX) · filed Aug 7, 2023

Accession no.
0000874716-23-000103
Filed
Aug 7, 2023
Trade date
Aug 3, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $8.17M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lane MichaelCIK 0001740689Officer (Executive Vice President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 3, 2023Common StockMOption exerciseAcquired+1,512$141.60+$214,099.25,545.99Direct
Aug 3, 2023Common StockMOption exerciseAcquired+7,435$178.26+$1,325,363.112,980.99Direct
Aug 3, 2023Common StockMOption exerciseAcquired+7,080$206.94+$1,465,135.220,060.99Direct
Aug 3, 2023Common StockSSaleDisposed−16,027$510.00F2−$8,173,7704,033.99Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2023Common StockMOption exerciseDisposed−1,512$0.00$00Direct
Aug 3, 2023Common StockMOption exerciseDisposed−7,435$0.00$00Direct
Aug 3, 2023Common StockMOption exerciseDisposed−7,080$0.00$01,286Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)